Dominik Ruettinger

Join Prof. Dr. Dominik Ruettinger, an oncological surgeon and Global Head of Research & Early Development Oncology at Bayer Pharmaceuticals, as he shares insights from his journey in cancer treatment innovation. He discusses the challenging 10% success rate in drug development and the importance of questioning traditional norms in biotech. Dominik explores the impact of AI in drug discovery and the delicate balance between quality of life and longevity for patients. His vision for future cancer prevention emphasizes early detection and personalized medicine.